drugset / Trial / NCT00746837
AZD5672 Absolute Bioavailability Study
RandomizedSingle-groupDouble-blindBasic science
Summary
The purpose of the study is to estimate the absolute bioavailability at steady state of 2 doses of AZD5672 (50 mg and 150 mg administered orally once daily)
Timeline
- Start
- 2008-08
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5672 | Small molecule | 7 mg | Intravenous |
| Subject | AZD5672 | Small molecule | 50 mg | Intravenous |
| Subject | AZD5672 | Small molecule | 150 mg | Intravenous |
Indications
No indication recorded.